Yasuyuki Kimura Selected Research

Yasuyuki Kimura Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2006
8	Cognitive Dysfunction 01/2022 - 08/2016
4	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 06/2013
3	Mental Disorders (Mental Disorder) 06/2018 - 01/2017
3	Hypertension (High Blood Pressure) 03/2010 - 01/2005
2	Neuroinflammatory Diseases 08/2022 - 01/2021
2	Dementia (Dementias) 01/2019 - 01/2017
2	Schizophrenia (Dementia Praecox) 01/2019 - 11/2017
2	Tauopathies 01/2017 - 12/2016
2	Moyamoya Disease (Moya-Moya Disease) 01/2008 - 04/2004
1	Narcolepsy 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Atherosclerosis 05/2021
1	Ischemic Stroke 05/2021
1	Vascular Diseases (Vascular Disease) 05/2021
1	Atrophy 01/2021
1	Asthma (Bronchial Asthma) 07/2020
1	Bradycardia 07/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Sleep Wake Disorders 08/2016
1	Amyloid Plaque 06/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2014
1	Cholangitis 01/2013
1	Lacunar Stroke 03/2010
1	Cerebral Small Vessel Diseases 03/2010
1	Inflammation (Inflammations) 01/2010
1	Stroke (Strokes) 12/2008
1	Coronary Disease (Coronary Heart Disease) 12/2008
1	Brain Neoplasms (Brain Tumor) 02/2007
1	Diaschisis 02/2007
1	Essential Hypertension 01/2005
1	Brain Diseases (Brain Disorder) 05/2004

Drug/Important Bio-Agent (IBA)

6	Amyloid (Amyloid Fibrils)IBA 01/2022 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2010
5	Pharmaceutical PreparationsIBA 01/2022 - 08/2016
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 12/2017 - 06/2013
4	LigandsIBA 01/2022 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2010
2	THK5351IBA 08/2022 - 01/2022
2	Monoamine Oxidase (MAO)IBA 08/2022 - 01/2022
2	Biological ProductsIBA 01/2022 - 01/2022
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2020 - 01/2019
2	benzothiazoleIBA 01/2019 - 01/2017
2	AminesIBA 06/2014 - 10/2006
2	Antihypertensive Agents (Antihypertensives)IBA 03/2010 - 01/2005
2	Oxygen (Dioxygen)IBA 01/2008 - 04/2004
2	Technetium Tc 99m Exametazime (Ceretec)FDA Link 10/2006 - 05/2004
1	Formaldehyde (Formol)FDA Link 05/2021
1	ParaffinIBA 05/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	tau Proteins (tau Protein)IBA 07/2020
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 11/2017
1	N-n-propylnorapomorphineIBA 11/2017
1	RacloprideIBA 11/2017
1	Antipsychotic Agents (Antipsychotics)IBA 11/2017
1	Therapeutic UsesIBA 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017
1	Nortriptyline (Aventyl)FDA LinkGeneric 04/2014
1	Milnacipran (Ixel)FDA Link 06/2013
1	Serotonin (5 Hydroxytryptamine)IBA 06/2013
1	Angiotensin Receptor AntagonistsIBA 03/2010
1	Valsartan (Vals)FDA Link 03/2010
1	Acetazolamide (Diamox)FDA LinkGeneric 03/2010
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2008
1	Methionine (L-Methionine)FDA Link 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 02/2007
1	propylene (propene)IBA 10/2006
1	OximesIBA 10/2006
1	Losartan (Cozaar)FDA LinkGeneric 01/2005
1	Radioisotopes (Radionuclides)IBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2013 - 03/2010
1	Carotid Endarterectomy 05/2021
1	Decompression 01/2013